Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers.

Nichols RJ, Haderk F, Stahlhut C, Schulze CJ, Hemmati G, Wildes D, Tzitzilonis C, Mordec K, Marquez A, Romero J, Hsieh T, Zaman A, Olivas V, McCoach C, Blakely CM, Wang Z, Kiss G, Koltun ES, Gill AL, Singh M, Goldsmith MA, Smith JAM, Bivona TG.

Nat Cell Biol. 2018 Sep;20(9):1064-1073. doi: 10.1038/s41556-018-0169-1. Epub 2018 Aug 13.

2.

Emerging application of genomics-guided therapeutics in personalized lung cancer treatment.

Zaman A, Bivona TG.

Ann Transl Med. 2018 May;6(9):160. doi: 10.21037/atm.2018.05.02. Review.

Supplemental Content

Loading ...
Support Center